Laura Klesse, MD, PhD - Building Strong Communities of Care in NF1: Collaborative Strategies and Management Choices With MEK Inhibitors for NF1-PNs Across Age Groups

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TJT865. CME/AAPA/IPCE credit will be available until June 16, 2027.Building Strong Communities of Care in NF1: Collaborative Strategies and Management Choices With MEK Inhibitors for NF1-PNs Across Age Groups In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Neurofibromatosis Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Alexion, AstraZeneca Rare Disease and SpringWorks Therapeutics, Inc.Disclosure information is available at the beginning of the video presentation.